BioAdvance
BioAdvance is a venture capital investment firm based in Conshohocken, Pennsylvania, that specializes in funding early-stage life sciences companies in Southeastern Pennsylvania. Established in 2002 with $33 million from the Commonwealth of Pennsylvania's tobacco settlement funds, BioAdvance manages the Greenhouse Fund, which has a total of $50 million available for investment. The firm focuses on therapeutics, medical devices, diagnostics, and platform technologies aimed at improving human health. Since its inception, BioAdvance has committed over $40 million to more than 50 seed-stage companies and 17 pre-seed companies, supporting the development of products to address various health issues, including Alzheimer's disease, cancer, obesity, and respiratory illnesses. By fostering innovation in the healthcare sector, BioAdvance has positioned itself as a leading investor in the region.
InfraScan
Seed Round in 2014
InfraScan, Inc. is a medical device company that specializes in developing and distributing hand-held diagnostic devices for assessing head injuries and strokes using near-infrared (NIR) technology. Its primary product, the Infrascanner, allows healthcare professionals to detect intracranial bleeding in patients with head trauma, which is crucial for timely intervention. The device is applicable in various settings, including hospitals, military operations, remote screenings, sports medicine, pediatrics, and ambulance services. InfraScan was founded in 2004 and is headquartered in Philadelphia, Pennsylvania, where it also operates a research and development lab. The company markets its products through a network of distributors across North America, South America, Africa, Asia, the Middle East, and Europe.
InfraScan
Seed Round in 2008
InfraScan, Inc. is a medical device company that specializes in developing and distributing hand-held diagnostic devices for assessing head injuries and strokes using near-infrared (NIR) technology. Its primary product, the Infrascanner, allows healthcare professionals to detect intracranial bleeding in patients with head trauma, which is crucial for timely intervention. The device is applicable in various settings, including hospitals, military operations, remote screenings, sports medicine, pediatrics, and ambulance services. InfraScan was founded in 2004 and is headquartered in Philadelphia, Pennsylvania, where it also operates a research and development lab. The company markets its products through a network of distributors across North America, South America, Africa, Asia, the Middle East, and Europe.
InfraScan
Seed Round in 2005
InfraScan, Inc. is a medical device company that specializes in developing and distributing hand-held diagnostic devices for assessing head injuries and strokes using near-infrared (NIR) technology. Its primary product, the Infrascanner, allows healthcare professionals to detect intracranial bleeding in patients with head trauma, which is crucial for timely intervention. The device is applicable in various settings, including hospitals, military operations, remote screenings, sports medicine, pediatrics, and ambulance services. InfraScan was founded in 2004 and is headquartered in Philadelphia, Pennsylvania, where it also operates a research and development lab. The company markets its products through a network of distributors across North America, South America, Africa, Asia, the Middle East, and Europe.
InfraScan
Seed Round in 2005
InfraScan, Inc. is a medical device company that specializes in developing and distributing hand-held diagnostic devices for assessing head injuries and strokes using near-infrared (NIR) technology. Its primary product, the Infrascanner, allows healthcare professionals to detect intracranial bleeding in patients with head trauma, which is crucial for timely intervention. The device is applicable in various settings, including hospitals, military operations, remote screenings, sports medicine, pediatrics, and ambulance services. InfraScan was founded in 2004 and is headquartered in Philadelphia, Pennsylvania, where it also operates a research and development lab. The company markets its products through a network of distributors across North America, South America, Africa, Asia, the Middle East, and Europe.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.